Management of Lobular Neoplasia Diagnosed by Core Biopsy
Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into three subtypes: classic LCIS, pleomorphic LCIS, and LCIS with necrosis (florid type). Becau...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | The Breast Journal |
Online Access: | http://dx.doi.org/10.1155/2023/8185446 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832559698899894272 |
---|---|
author | Chinmay Jani Margaret Lotz Sarah Keates Yasha Gupta Alexander Walker Omar Al Omari Arshi Parvez Dipesh Patel Maria Gnata John Perry Leila Khorashadi Lisa Weissmann Susan E. Pories |
author_facet | Chinmay Jani Margaret Lotz Sarah Keates Yasha Gupta Alexander Walker Omar Al Omari Arshi Parvez Dipesh Patel Maria Gnata John Perry Leila Khorashadi Lisa Weissmann Susan E. Pories |
author_sort | Chinmay Jani |
collection | DOAJ |
description | Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into three subtypes: classic LCIS, pleomorphic LCIS, and LCIS with necrosis (florid type). Because classic LCIS is now considered as a benign etiology, current guidelines recommend close follow-up with imaging versus surgical excision. The goal of our study was to determine if the diagnosis of classic LN on core needle biopsy (CNB) merits surgical excision. This is a retrospective, observational study conducted at Mount Auburn Hospital, Cambridge, MA, from May 17, 2017, through June 30, 2020. We reviewed the data of breast biopsies conducted at our hospital over this period and included patients who were diagnosed with classic LN (LCIS and/or ALH) and excluded patients having any other atypical lesions on CNB. All known cancer patients were excluded. Of the 2707 CNBs performed during the study period, we identified 68 women who were diagnosed with ALH or LCIS on CNB. CNB was performed for an abnormal mammogram in the majority of patients (60; 88%) while 7(10.3%) had an abnormal breast magnetic resonance imaging study (MRI), and 1 had an abnormal ultrasound (US). A total of 58 patients (85%) underwent excisional biopsy, of which 3 (5.2%) showed malignancy, including 2 cases of DCIS and 1 invasive carcinoma. In addition, there was 1 case (1.7%) with pleomorphic LCIS and 11 cases with ADH (15.5%). The management of LN found on core biopsy is evolving, with some advocating surgical excision and others recommending observation. Our data show a change in diagnosis with excisional biopsy in 13 (22.4%) of patients with 2 cases of DCIS, 1 invasive carcinoma, 1 pleomorphic LCIS, and 9 cases of ADH, diagnosed on excisional biopsy. While ALH and classic LCIS are considered benign, the choice of ongoing surveillance versus excisional biopsy should be made with shared decision making with the patient, with consideration of personal and family history, as well as patient preferences. |
format | Article |
id | doaj-art-713800bea15049509e325a385f518b05 |
institution | Kabale University |
issn | 1524-4741 |
language | English |
publishDate | 2023-01-01 |
publisher | Wiley |
record_format | Article |
series | The Breast Journal |
spelling | doaj-art-713800bea15049509e325a385f518b052025-02-03T01:29:27ZengWileyThe Breast Journal1524-47412023-01-01202310.1155/2023/8185446Management of Lobular Neoplasia Diagnosed by Core BiopsyChinmay Jani0Margaret Lotz1Sarah Keates2Yasha Gupta3Alexander Walker4Omar Al Omari5Arshi Parvez6Dipesh Patel7Maria Gnata8John Perry9Leila Khorashadi10Lisa Weissmann11Susan E. Pories12Department of Internal MedicineHarvard Medical SchoolHarvard Medical SchoolHarvard Medical SchoolDepartment of Internal MedicineDepartment of Internal MedicineDepartment of Internal MedicineHarvard Medical SchoolHoffman Breast CenterDepartment of PathologyHarvard Medical SchoolDepartment of Internal MedicineHarvard Medical SchoolLobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into three subtypes: classic LCIS, pleomorphic LCIS, and LCIS with necrosis (florid type). Because classic LCIS is now considered as a benign etiology, current guidelines recommend close follow-up with imaging versus surgical excision. The goal of our study was to determine if the diagnosis of classic LN on core needle biopsy (CNB) merits surgical excision. This is a retrospective, observational study conducted at Mount Auburn Hospital, Cambridge, MA, from May 17, 2017, through June 30, 2020. We reviewed the data of breast biopsies conducted at our hospital over this period and included patients who were diagnosed with classic LN (LCIS and/or ALH) and excluded patients having any other atypical lesions on CNB. All known cancer patients were excluded. Of the 2707 CNBs performed during the study period, we identified 68 women who were diagnosed with ALH or LCIS on CNB. CNB was performed for an abnormal mammogram in the majority of patients (60; 88%) while 7(10.3%) had an abnormal breast magnetic resonance imaging study (MRI), and 1 had an abnormal ultrasound (US). A total of 58 patients (85%) underwent excisional biopsy, of which 3 (5.2%) showed malignancy, including 2 cases of DCIS and 1 invasive carcinoma. In addition, there was 1 case (1.7%) with pleomorphic LCIS and 11 cases with ADH (15.5%). The management of LN found on core biopsy is evolving, with some advocating surgical excision and others recommending observation. Our data show a change in diagnosis with excisional biopsy in 13 (22.4%) of patients with 2 cases of DCIS, 1 invasive carcinoma, 1 pleomorphic LCIS, and 9 cases of ADH, diagnosed on excisional biopsy. While ALH and classic LCIS are considered benign, the choice of ongoing surveillance versus excisional biopsy should be made with shared decision making with the patient, with consideration of personal and family history, as well as patient preferences.http://dx.doi.org/10.1155/2023/8185446 |
spellingShingle | Chinmay Jani Margaret Lotz Sarah Keates Yasha Gupta Alexander Walker Omar Al Omari Arshi Parvez Dipesh Patel Maria Gnata John Perry Leila Khorashadi Lisa Weissmann Susan E. Pories Management of Lobular Neoplasia Diagnosed by Core Biopsy The Breast Journal |
title | Management of Lobular Neoplasia Diagnosed by Core Biopsy |
title_full | Management of Lobular Neoplasia Diagnosed by Core Biopsy |
title_fullStr | Management of Lobular Neoplasia Diagnosed by Core Biopsy |
title_full_unstemmed | Management of Lobular Neoplasia Diagnosed by Core Biopsy |
title_short | Management of Lobular Neoplasia Diagnosed by Core Biopsy |
title_sort | management of lobular neoplasia diagnosed by core biopsy |
url | http://dx.doi.org/10.1155/2023/8185446 |
work_keys_str_mv | AT chinmayjani managementoflobularneoplasiadiagnosedbycorebiopsy AT margaretlotz managementoflobularneoplasiadiagnosedbycorebiopsy AT sarahkeates managementoflobularneoplasiadiagnosedbycorebiopsy AT yashagupta managementoflobularneoplasiadiagnosedbycorebiopsy AT alexanderwalker managementoflobularneoplasiadiagnosedbycorebiopsy AT omaralomari managementoflobularneoplasiadiagnosedbycorebiopsy AT arshiparvez managementoflobularneoplasiadiagnosedbycorebiopsy AT dipeshpatel managementoflobularneoplasiadiagnosedbycorebiopsy AT mariagnata managementoflobularneoplasiadiagnosedbycorebiopsy AT johnperry managementoflobularneoplasiadiagnosedbycorebiopsy AT leilakhorashadi managementoflobularneoplasiadiagnosedbycorebiopsy AT lisaweissmann managementoflobularneoplasiadiagnosedbycorebiopsy AT susanepories managementoflobularneoplasiadiagnosedbycorebiopsy |